These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 78945)
1. Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils. Dembo M; Goldstein B J Immunol; 1978 Jul; 121(1):345-53. PubMed ID: 78945 [TBL] [Abstract][Full Text] [Related]
2. Test of a theory relating to the cross-linking of IgE antibody on the surface of human basophils. MacGlashan DW; Dembo M; Goldstein B J Immunol; 1985 Dec; 135(6):4129-34. PubMed ID: 2415601 [TBL] [Abstract][Full Text] [Related]
3. Histamine release due to bivalent penicilloyl haptens: control by the basophil plasma membrane. Dembo M; Goldstein B; Sobotka AK; Lichtenstein LM J Immunol; 1978 Jul; 121(1):354-8. PubMed ID: 78946 [TBL] [Abstract][Full Text] [Related]
4. Theory of equilibrium binding of asymmetric bivalent haptens to cell surface antibody: application to histamine release from basophils. Wofsy C; Goldstein B; Dembo M J Immunol; 1978 Aug; 121(2):593-601. PubMed ID: 79608 [No Abstract] [Full Text] [Related]
5. Histamine release due to bivalent penicilloyl haptens the relation of activation and desensitization of basophils to dynamic aspects of ligand binding to cell surface antibody. Dembo M; Goldstein B; Sobotka AK; Lichtenstein LM J Immunol; 1979 Feb; 122(2):518-28. PubMed ID: 84026 [No Abstract] [Full Text] [Related]
6. Computer calculation of multiple binding equilibrium isotherms: application to the binding of bivalent ligands to antibodies interacting with cell surface Fc-receptors. Barbet J; Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M J Theor Biol; 1993 Dec; 165(3):321-40. PubMed ID: 8114501 [TBL] [Abstract][Full Text] [Related]
7. Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking. Goldstein B; Wofsy C J Math Biol; 1980 Dec; 10(4):347-66. PubMed ID: 7276759 [TBL] [Abstract][Full Text] [Related]
8. Degranulation of human basophils: quantitative analysis of histamine release and desensitization, due to a bivalent penicilloyl hapten. Dembo M; Goldstein B; Sobotka AK; Lichtenstein LM J Immunol; 1979 Oct; 123(4):1864-72. PubMed ID: 90102 [No Abstract] [Full Text] [Related]
9. Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. MacGlashan D; Lichtenstein LM J Immunol; 1983 May; 130(5):2330-6. PubMed ID: 6187850 [TBL] [Abstract][Full Text] [Related]
10. Hapten-modified basophils: a model of human immediate hypersensitivity that can be elicited by IgG antibody. Akiyama K; Pruzansky JJ; Patterson R J Immunol; 1984 Dec; 133(6):3286-90. PubMed ID: 6208277 [TBL] [Abstract][Full Text] [Related]
11. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Janevik-Ivanovska E; Gautherot E; Hillairet de Boisferon M; Cohen M; Milhaud G; Tartar A; Rostene W; Barbet J; Gruaz-Guyon A Bioconjug Chem; 1997; 8(4):526-33. PubMed ID: 9258451 [TBL] [Abstract][Full Text] [Related]
12. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results. Le Doussal JM; Barbet J; Delaage M Int J Cancer Suppl; 1992; 7():58-62. PubMed ID: 1428406 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. MacGlashan DW; Peters SP; Warner J; Lichtenstein LM J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427 [TBL] [Abstract][Full Text] [Related]
14. Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails. Le Doussal JM; Gautherot E; Martin M; Barbet J; Delaage M J Immunol; 1991 Jan; 146(1):169-75. PubMed ID: 1984443 [TBL] [Abstract][Full Text] [Related]
15. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. Kaufman EN; Jain RK Cancer Res; 1992 Aug; 52(15):4157-67. PubMed ID: 1638531 [TBL] [Abstract][Full Text] [Related]
16. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. Abbas AK; Haber S; Rock KL J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498 [TBL] [Abstract][Full Text] [Related]
17. The effect of co-operativity on the equilibrium binding of symmetric bivalent ligands to antibodies: theoretical results with application to histamine release from basophils. Wofsy C; Goldstein B Mol Immunol; 1987 Feb; 24(2):151-61. PubMed ID: 2441249 [TBL] [Abstract][Full Text] [Related]
18. Cross-linking of Fc gamma receptors and surface antibodies. Theory and application. Wofsy C; Goldstein B J Immunol; 1990 Sep; 145(6):1814-25. PubMed ID: 2144009 [TBL] [Abstract][Full Text] [Related]
19. Cross-linking of IgE-receptor complexes at the cell surface: a fluorescence method for studying the binding of monovalent and bivalent haptens to IgE. Erickson J; Kane P; Goldstein B; Holowka D; Baird B Mol Immunol; 1986 Jul; 23(7):769-81. PubMed ID: 2948110 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of the free and liganded form of an esterolytic catalytic antibody. Wedemayer GJ; Wang LH; Patten PA; Schultz PG; Stevens RC J Mol Biol; 1997 May; 268(2):390-400. PubMed ID: 9159478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]